Good Biotech Corp. 最新消息

The Patent has also been granted in EU

www.good-biotech.com — 1970-01-01T00:00:00+01:00

The one and only one patent owner for production & applications of IgY(ΔFc) antibodies in the world. This commercialized technology is solely owned by GBC and is also patented-protected worldwide including all the major and dominant markets. The patents have been granted by many countries so far such as United States, Japan, Russia, Australia, China, Taiwan, New Zealand, Singapore, Malaysia, Hong Kong etc...and now has also been granted in European Union.

Human Albumin/IgG/Transferrin Depletion Column

www.good-biotech.com — 1970-01-01T00:00:00+01:00

REF HD-0301-10GFC

GBC Human Albumin/IgG/Transferrin 3 in 1 Depletion Column is designed to specifically remove albumin, IgG and transferrin from human serum/plasma for various downstream applications, e.g. 1DE, 2DE, and LC/MS. The affinity medium in the spin column is the resin coupled with duck anti-human albumin, anti-IgG, and anti-transferrin affinity purified IgYΔFc polyclonal antibodies. Each GBC Human 3 in 1 Depletion Column contains a gravity-flow column packed with 4ml affinity resin resin. The depletion spin column can remove greater than 98% of the albumin, IgG and transferrin from a 200 µl serum sample and yield about 3.0-3.4 mg/sample of total protein after single depletion process.

Features and Benefits

ü Efficient removal of albumin, IgG and transferrin by immunoaffinity capture from serum samples

ü High specific with minimal loss of other serum biomarkers

ü Fast and simple gravity-based procedure, applicable for multiple processing

ü Sufficient amount of enriched proteins from 200ml serum/plasma for one process

ü Not bind mammalian complement factor, rheumatoid factor, IgM, Fc receptor

ü Application to 1D or 2D electrophoresis, LC/MS, etc.

ü Re-usable for more than 200 cycles,cost effective for each single run

Click here for further information about these series products.

Antivenom publication

www.good-biotech.com — 1970-01-01T00:00:00+01:00

Good Biotech Corp. (GBC), an unprecedented duck IgY(ΔFc) antibody manufacturer based in Taiwan, has successfully built up the technology platform by using ducks as bio-reactors to produce a novel IgY(ΔFc) polyclonal antibody from hyperimmune duck egg yolk. Based upon the cutting edge technology and the unique characteristics of duck IgY(ΔFc) antibody, GBC gained positive results on the development of IgY(ΔFc) derived snake antivenins, digoxin immune Fab and neutralizing antibodies against pathogens of bacteria, virus etc. Without having the disadvantage & limitation of traditional horse, sheep based antibodies and in the meantime, having the advantages of highly specific, high efficacy, high productivity and safety, IgY(ΔFc) antibody can be the best candidate for the new generation of Biotherapeutics.

The development of IgY(ΔFc) antibody based neuro toxin antivenoms and the study on their neutralization efficacies.

Clinical Toxicology (2008 July ; Volume 46 Issue 6, 539-544 )

New CRP-serum/plasma/whole blood

www.good-biotech.com — 1970-01-01T00:00:00+01:00

The new generation CRP immunoassay kit-Triplex CRP LIT Assay (REF: KT-0301-D) from Good Biotech Corp.enables precise and accurate determination of C-reactive protein (CRP) in capillary or venous whole blood, plasma or serum. It is designed for use in two applications (Universal mode and High Sensitivity mode) by using different parameter settings. The Universal mode is used for CRP determination in various kinds of specimens, including plasma, serum and whole blood; the High Sensitivity mode is recommended for serum/plasma samples with CRP concentrations below 20 mg/L and where high precision and extremely good sensitivity is required.

The assay is simple, rapid, and can be cost-effectively performed on common automated chemistry analyzers or the bench-top analyzers. The use of whole blood for CRP measurement eliminates the need for sample centrifugation or transportation and thus is suitable for rapid point-of-care testing. Near-patient monitoring of CRP in real time may reduce costs and is beneficial for improved patient care.

FEATURES

Easy and reliable performance of the test

Use of whole blood, as well as serum and plasma

Test result available in minutes

Adaptable to general clinical chemistry analyzers

Quantitative results

Reliable assay range of up to 300 mg/L (Universal mode

with using serum/plasma specimens) or 20 mg/L (High

Sensitivity mode)

Click here for further information about this product.